Renal Cancer
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors (XL092-002)
- Details
ClinicalTrials.gov ID:
NCT05176483
Diagnosis Type:
NA
USOR Number:
- Address
,
P: